#CVpad - Twitter Hashtag

5 days ago

In the prospective, real-world PROSPECT MONSTER study, second-generation low-dose DCB demonstrated 3-year clinical outcomes comparable to first-generation high-dose DCB in pts w/ complex femoropopliteal artery disease. #JACCCEP #cvPAD https://t.co/xp7ZFqpXNr

JACCJournals's tweet photo. In the prospective, real-world PROSPECT MONSTER study, second-generation low-dose DCB demonstrated 3-year clinical outcomes comparable to first-generation high-dose DCB in pts w/ complex femoropopliteal artery disease.

#JACCCEP #cvPAD

https://t.co/xp7ZFqpXNr https://t.co/Df6777AVrC

0

36

8

5

7K

JACC Journals @JACCJournals

10 days ago

Six 15-min sessions of microbubble cavitation over 18 days increased microvascular density 1.6-fold and femoral flow 1.8-fold, promoting ulcer healing in no-option CLTI. A small trial, but a potential new avenue. #JACCIMG #cvPAD #cvImaging https://t.co/FUmXBZRcAS

JACCJournals's tweet photo. Six 15-min sessions of microbubble cavitation over 18 days increased microvascular density 1.6-fold and femoral flow 1.8-fold, promoting ulcer healing in no-option CLTI. A small trial, but a potential new avenue.

#JACCIMG #cvPAD #cvImaging

https://t.co/FUmXBZRcAS https://t.co/MqYk74eH4d

0

20

4

6

4K

American College of Cardiology @ACCinTouch

21 days ago

A three-part PAD series underscores the growing global impact of #cvPAD and reinforces the need for earlier diagnosis, improved treatment and better access to care. Get full details in the journal scan ➡️ https://t.co/0QGmyqmnai #CardioX

2

4

0

1

4K

American College of Cardiology @ACCinTouch

26 days ago

Encourage patients to visit #CardioSmart’s #cvPAD Resource Hub for information on symptoms, diagnosis, treatment and the importance of exercise and risk factor management during this September, #PADAwarenessMonth. Learn more: https://t.co/EEH6Ocj8zR #CardioX

ACCinTouch's tweet photo. Encourage patients to visit #CardioSmart’s #cvPAD Resource Hub for information on symptoms, diagnosis, treatment and the importance of exercise and risk factor management during this September, #PADAwarenessMonth.

Learn more: https://t.co/EEH6Ocj8zR #CardioX https://t.co/ES9fzqxBxf

1

18

4

0

5K

American College of Cardiology @ACCinTouch

about 1 month ago

The SirPAD trial data established sirolimus-coated balloon angioplasty as an effective alternative to uncoated-balloon angioplasty for infrainguinal #cvPAD, with meaningful reductions in both amputation and CLI-driven #Revascularization. 🔗 Learn more: https://t.co/OWSTXEkE9d

ACCinTouch's tweet photo. The SirPAD trial data established sirolimus-coated balloon angioplasty as an effective alternative to uncoated-balloon angioplasty for infrainguinal #cvPAD, with meaningful reductions in both amputation and CLI-driven #Revascularization.

🔗 Learn more: https://t.co/OWSTXEkE9d https://t.co/87i6DTkZdh

0

15

4

1

3K

JACC Journals @JACCJournals

about 2 months ago

New drug-balloon option for femoropopliteal disease? SIRONA RCT showed that sirolimus-coated balloons had noninferior 12-month clinical outcomes vs paclitaxel-coated balloons. Long-term follow-up is ongoing. Read more in #JACC: https://t.co/buI1Oka4ub #cvPAD

JACCJournals's tweet photo. New drug-balloon option for femoropopliteal disease? SIRONA RCT showed that sirolimus-coated balloons had noninferior 12-month clinical outcomes vs paclitaxel-coated balloons. Long-term follow-up is ongoing. Read more in #JACC: https://t.co/buI1Oka4ub #cvPAD https://t.co/mY4fNtP2mi

1

17

4

1

4K

JACC Journals @JACCJournals

4 months ago

Does a resorbable scaffold lose its edge in PAD once it's gone? Nope! Head-to-head against angioplasty for CLTI, the Esprit BTK DRS had less stenosis and fewer reinterventions, with comparable safety. https://t.co/gb0C1Ww2qL #JACC #cvPAD @MarcBonaca @sahilparikhmd

JACCJournals's tweet photo. Does a resorbable scaffold lose its edge in PAD once it's gone? Nope! Head-to-head against angioplasty for CLTI, the Esprit BTK DRS had less stenosis and fewer reinterventions, with comparable safety. https://t.co/gb0C1Ww2qL

#JACC #cvPAD @MarcBonaca @sahilparikhmd https://t.co/qufjU1hCwz

0

22

9

2

4K

ACC Media Center

@ACCmediacenter

4 months ago

Borderline ankle-brachial index is linked with a higher risk for major adverse limb events among people with #cvPAD, a new #JACC study shows. https://t.co/CQmRGPeta5 @CardioAdvisor

0

3

1

0

414

ACC Media Center

@ACCmediacenter

4 months ago

Patients with #cvPAD who follow pre-operative guideline-directed care have a reduced risk of major adverse limb events, new research shows. https://t.co/MF4PPhmCpW @CardioBusiness

0

2

0

295

American College of Cardiology @ACCinTouch

4 months ago

A quick, noninvasive toe-based light measurement combined with #AI demonstrated efficacy in screening for #cvPAD, according to a recent study published by a 2024 recipient of an #ACCAccreditation Services' QI.PI Project Grant. Get full details 👉 https://t.co/q2jahxvcPK #cvQI

0

5

0

1K

American College of Cardiology @ACCinTouch

7 months ago

🔑 #AI–driven diagnostic tools can enhance early detection and improve outcomes by analyzing complex vascular imaging data in conditions such as #cvPAD, pulmonary embolism, and carotid artery disease. Get more insights ➡️ https://t.co/CpY1LMsAqK #cvPrev

0

11

6

0

2K

JACC Journals @JACCJournals

7 months ago

In a single-center CT-based analysis of 336 Japanese pts undergoing #TAVR, overall suitability for transcarotid access was high (91%)🎯 Peripheral artery disease was the only independent negative predictor (OR 0.42). https://t.co/PVKCApfxUa #JACCAsia #vhdAS #cvPAD @enta_yusuke

JACCJournals's tweet photo. In a single-center CT-based analysis of 336 Japanese pts undergoing #TAVR, overall suitability for transcarotid access was high (91%)🎯

Peripheral artery disease was the only independent negative predictor (OR 0.42). https://t.co/PVKCApfxUa

#JACCAsia #vhdAS #cvPAD @enta_yusuke https://t.co/IpAKzWCDT5

1

26

6

3K

American College of Cardiology @ACCinTouch

7 months ago

Together, #ACCAdvocacy, #ACCChapters & Member Sections have spearheaded efforts to improve #AEDAccess, maternal health outcomes & coverage for #cvPAD screening. Learn more at #ACC26 on the Heart2Heart stage! ACC is championing access to care for all: https://t.co/dsOQaYfltu

ACCinTouch's tweet photo. Together, #ACCAdvocacy, #ACCChapters & Member Sections have spearheaded efforts to improve #AEDAccess, maternal health outcomes & coverage for #cvPAD screening.

Learn more at #ACC26 on the Heart2Heart stage! ACC is championing access to care for all: https://t.co/dsOQaYfltu https://t.co/zEaMJdR75A

0

6

2

0

1K

Duke Clinical Research Institute @DCRINews

7 months ago

Day 1 of #ACC26 is here! DCRI faculty are sharing the knowledge you need on #cvPrev, #AFib care, #cvACS, #cvPAD, and #cvMI, before capping off the day with a FIT Mix 'N' Mingle networking event. Learn more about DCRI’s thought leadership: https://t.co/FMz0TkJ9VL #CardioX

DCRINews's tweet photo. Day 1 of #ACC26 is here! DCRI faculty are sharing the knowledge you need on #cvPrev, #AFib care, #cvACS, #cvPAD, and #cvMI, before capping off the day with a FIT Mix 'N' Mingle networking event. Learn more about DCRI’s thought leadership: https://t.co/FMz0TkJ9VL #CardioX https://t.co/0foqrxCzeI

0

10

1

2

761

Gwills💙

@Gwills_digital

7 months ago

When your bro is still doubting $CVAI… and you’re there like Look, I’m pointing you to the future, don’t say I didn’t tell you’👉📈😂 #OGCVPAD $CVAI #CVPAD

Gwills_digital's tweet photo. When your bro is still doubting $CVAI… and you’re there like
Look, I’m pointing you to the future, don’t say I didn’t tell you’👉📈😂

#OGCVPAD $CVAI #CVPAD https://t.co/RHeyCaA5La

2

24

0

141

ACC Advocacy @Cardiology

7 months ago

.@APKithcartMDPhD + other @NYSCACC members discussed noncompete reform, prior auth, funding for #AEDAccess and #cvPAD awareness with state lawmakers at a recent advocacy event. #ACCAdvocacy

Cardiology's tweet photo. .@APKithcartMDPhD + other @NYSCACC members discussed noncompete reform, prior auth, funding for #AEDAccess and #cvPAD awareness with state lawmakers at a recent advocacy event. #ACCAdvocacy https://t.co/lMTVWpHZ4q

0

3

2

1

643

𝘾𝙖𝙩 𝙢𝙖𝙧𝙞𝙤 🐱 @sathosiAI

9 months ago

@CVPad_io hodl 1 nft 0x6e3947a846d3d6b9ca5aa89bbf62c18492f08e89 #cvpad

0

4

0

17

Khennie⚡ @Khenny606

9 months ago

CVMech was never designed as a simple free mint.  It is the foundational NFT of the CVPad ecosystem and a long-term access pass for early supporters. Holding CVMech means positioning yourself at the core of what CVPad is building. 🧵 ⬇️ #CVPad @CVPad_io

Khenny606's tweet photo. CVMech was never designed as a simple free mint.
 It is the foundational NFT of the CVPad ecosystem and a long-term access pass for early supporters.

Holding CVMech means positioning yourself at the core of what CVPad is building.
🧵 ⬇️
#CVPad @CVPad_io https://t.co/ytBJQRLwzP

24

11

3

0

290

Khennie⚡ @Khenny606

9 months ago

@CVPad_io The CVPad Jackpot is more than numbers, it’s community, growth, and recognition. Thank you for being part of this story. #CVPad #Crypto @CVPad_io

0

3

0

39

Khennie⚡ @Khenny606

9 months ago

CVPad Jackpot Reminder! As we approach the snapshot, we want to take a moment to appreciate our amazing community of $CVAI holders and NFT supporters. @CVPad_io #CVPad #CVAI

Khenny606's tweet photo. CVPad Jackpot Reminder!

As we approach the snapshot, we want to take a moment to appreciate our amazing community of $CVAI holders and NFT supporters. @CVPad_io

#CVPad #CVAI https://t.co/SuOOQOTtsn

33

18

3

0

129

Top Tweets for #CVpad

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users